Giraudo Bryan's most recent trade in Protagonist Therapeutics Inc was a trade of 36,000 Common Stock done at an average price of $100.1 . Disclosure was reported to the exchange on May 7, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Sale of securities on an exchange or to another person at price $ 100.14 per share. | 07 May 2026 | 36,000 | 27,825 (0%) | 0% | 100.1 | 3,605,040 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2026 | 24,000 | 0 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.45 per share. | 07 May 2026 | 24,000 | 31,825 (0%) | 0% | 6.5 | 154,800 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Sale of securities on an exchange or to another person at price $ 100.07 per share. | 07 May 2026 | 12,000 | 6,000 (0%) | 0% | 100.1 | 1,200,840 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.98 per share. | 07 May 2026 | 12,000 | 43,825 (0%) | 0% | 7.0 | 83,760 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 May 2026 | 12,000 | 0 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 07 May 2026 | 6,000 | 0 (0%) | 0% | 100 | 600,000 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Sale of securities on an exchange or to another person at price $ 100.00 per share. | 07 May 2026 | 5,130 | 12,695 (0%) | 0% | 100 | 513,000 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 693,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 693,750 | 693,750 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 638,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 638,000 | 638,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 543,750 | 543,750 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 543,750 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 211,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 211,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 211,500 | 211,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 211,500 | 211,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 181,250 | 181,250 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 181,250 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 176,667 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 176,667 | 176,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 100,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 96,667 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 96,667 | 96,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Mar 2026 | 47,667 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2026 | 47,667 | 47,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 693,750 | 693,750 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 115,750 | 389,737 (0%) | 0% | 0 | Common Stock | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 3,762 | 3,762 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 2,695 | 17,825 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 181,250 | 273,987 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 638,000 | 638,000 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 6,584 | 6,584 | - | - | Stock Option (right to buy) | |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 5,130 | 15,130 (0%) | 0% | 0 | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 0.59 per share. | 18 Jun 2024 | 100,000 | 480,010 (0%) | 0% | 0.6 | 59,110 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale of securities on an exchange or to another person at price $ 1.16 per share. | 27 Mar 2024 | 6,430 | 92,737 (0%) | 0% | 1.2 | 7,431 | Common Stock |
| Gossamer Bio Inc | Giraudo Bryan | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 543,750 | 543,750 | - | - | Stock Option (Right to Buy) | |
| Protagonist Therapeutics Inc | Giraudo Bryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 25,700 | 25,700 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 1.82 per share. | 24 Jul 2023 | 54,020 | 180,010 (0%) | 0% | 1.8 | 98,316 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 13,505 | 13,505 | - | - | Common Stock | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 265,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 176,667 | 176,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 150,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 145,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 96,667 | 96,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 90,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 May 2023 | 71,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 May 2023 | 47,667 | 47,667 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 1.02 per share. | 04 Apr 2023 | 55,000 | 125,990 (0%) | 0% | 1.0 | 56,095 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 211,500 | 211,500 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 0.97 per share. | 20 Mar 2023 | 50,000 | 70,990 (0%) | 0% | 1.0 | 48,435 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2023 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Purchase of securities on an exchange or from another person at price $ 7.21 per share. | 15 Jul 2022 | 13,869 | 20,990 (0%) | 0% | 7.2 | 99,995 | Common Stock |
| Protagonist Therapeutics Inc | Bryan Giraudo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Sale of securities on an exchange or to another person at price $ 8.92 per share. | 23 Mar 2022 | 10,722 | 99,167 (0%) | 0% | 8.9 | 95,587 | Common Stock |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2022 | 265,000 | 265,000 | - | - | Stock Option (Right to Buy) | |
| Gossamer Bio Inc | Bryan Giraudo | COO/CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) |